Format

Send to

Choose Destination
Oxid Med Cell Longev. 2015;2015:536962. doi: 10.1155/2015/536962. Epub 2015 Sep 20.

NSAIDs and Cardiovascular Diseases: Role of Reactive Oxygen Species.

Author information

1
Department of Neurobiology, Physiology, and Behavior, University of California, Davis, CA 95616, USA.
2
Department of Neurobiology, Physiology, and Behavior, University of California, Davis, CA 95616, USA ; Department of Physiology and Membrane Biology, University of California, Davis, CA 95616, USA.

Abstract

Nonsteroidal anti-inflammatory drugs (NSAIDs) are the most commonly used drugs worldwide. NSAIDs are used for a variety of conditions including pain, rheumatoid arthritis, and musculoskeletal disorders. The beneficial effects of NSAIDs in reducing or relieving pain are well established, and other benefits such as reducing inflammation and anticancer effects are also documented. The undesirable side effects of NSAIDs include ulcers, internal bleeding, kidney failure, and increased risk of heart attack and stroke. Some of these side effects may be due to the oxidative stress induced by NSAIDs in different tissues. NSAIDs have been shown to induce reactive oxygen species (ROS) in different cell types including cardiac and cardiovascular related cells. Increases in ROS result in increased levels of oxidized proteins which alters key intracellular signaling pathways. One of these key pathways is apoptosis which causes cell death when significantly activated. This review discusses the relationship between NSAIDs and cardiovascular diseases (CVD) and the role of NSAID-induced ROS in CVD.

PMID:
26457127
PMCID:
PMC4592725
DOI:
10.1155/2015/536962
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Hindawi Limited Icon for PubMed Central
Loading ...
Support Center